RSBG SE, which has its headquarters in Essen, is a holding subsidiary of the RAG-Stiftung. Our shareholdings generate a part of the income that the RAG-Stiftung uses to finance the perpetual obligations resulting from Germany’s hard coal mining industry.

Klaus has been at home in the world of high-tech industrial plants for decades and has more than 20 years of management experience. He began his career at Thyssen Krupp Uhde in Dortmund. He also worked for the companies Lurgi Lifescience GmbH (CEO), Pharmaplan/Pharmatec Group (CEO) and MAN Ferrostaal AG (Member of the Executive Board). In the wake of an acquisition, Klaus was appointed CEO of Ferrostaal. Since 2018, he has been a managing shareholder of DIAG – Deutsche Industrieanlagen GmbH. Since June 2021, he has been sharing his in-depth specialist and industry knowledge as well as his international business experience with RSBG SE in the role of CEO. Klaus holds a doctorate in engineering from RWTH Aachen University.

After studying law at the Westfälische Wilhelms University (WWU) of Münster, Jan initially worked as a research assistant at the Institute for International Business Law at the WWU. During this time he did his doctorate on the subject of “Creditor protection and shareholder liability in cash pooling”. After teaching and research stays in Beijing, among other places, and a legal clerkship in Düsseldorf and Washington, D.C., Jan began his professional career as a lawyer in the Corporate/M&A department at Clifford Chance LLP in Düsseldorf. Since the beginning of 2015, Jan has been entrusted with the establishment and further development of RSBG SE, of which he has been COO since August 2021. Jan has more than ten years of experience in national and international M&A business, restructuring and portfolio management with a focus on investments in the areas of pharmaceuticals and life sciences, industrial automation and robotics, high-tech manufacturing, and digitalization solutions and media technology.